New asthma drugs acting on gene expression
Open Access
- 1 October 2003
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 7 (4) , 475-486
- https://doi.org/10.1111/j.1582-4934.2003.tb00251.x
Abstract
New asthma drugs acting on transcription are transcription factor agonists (dissociated steroids, peroxisome proliferator‐activated receptor gamma agonists), transcription factor inhibitors (NF‐kB / AP‐1 inhibitors, STAT6 inhibitors), inhibitors of protein kinases acting on transcription factors (p38 MAP kinase inhibitors), and chromatin modifying agents. Pharmacological approach of translation in asthma includes therapeutic ribozymes and antisense oligonucleotides targeting receptors (adenosine A1 receptor, alpha chain of IL‐5 receptor, common beta chain of IL‐3/IL‐5/GM‐CSF receptor), cytokines (IL‐4, IL‐5, SCF), signal transduction molecules (Syk, Lyn), transcription factors (STAT‐6, GATA‐3). Some of these drugs acting on gene expression have the potential to improve therapeutic benefits compared with traditional drugs.Keywords
This publication has 26 references indexed in Scilit:
- New asthma drugs acting on gene expressionJournal of Cellular and Molecular Medicine, 2003
- Respirable antisense oligonucleotides: a new, third drug class targeting respiratory diseaseCurrent Opinion in Allergy and Clinical Immunology, 2002
- Missing Pieces in the NF-κB PuzzleCell, 2002
- A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen‐exposed ratBritish Journal of Pharmacology, 2001
- Antisense TherapyPublished by S. Karger AG ,2001
- Chromatin ModificationPublished by S. Karger AG ,2001
- Ribozyme TherapyPublished by S. Karger AG ,2001
- Inhibition of p38 MAP KinasePublished by S. Karger AG ,2001
- Molecular mechanisms of glucocorticoid action: what is important?Thorax, 2000
- Adoptively transferred late allergic response is inhibited by IL-4, but not IL-5, antisense oligonucleotideJournal of Allergy and Clinical Immunology, 1999